Literature DB >> 35325356

The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Haiqiong Ye1,2,3, Yue Han1,2,3, Ping Li1,2,3, Zhengding Su1,2,3, Yongqi Huang4,5,6.   

Abstract

Involving addition of chemical groups or protein units to specific residues of the target protein, post-translational modifications (PTMs) alter the charge, hydrophobicity, and conformation of a protein, which in tune influences protein function, protein - protein interaction, and protein aggregation. While the occurrence of PTMs is dynamic and subject to regulations, conformational disorder of the target protein facilitates PTMs. The microtubule-associated protein tau is a typical intrinsically disordered protein that undergoes a variety of PTMs including phosphorylation, acetylation, ubiquitination, methylation, and oxidation. Accumulated evidence shows that these PTMs play a critical role in regulating tau-microtubule interaction, tau localization, tau degradation and aggregation, and reinforces the correlation between tau PTMs and pathogenesis of neurodegenerative disease. Here, we review tau PTMs with an emphasis on their influence on tau structure. With available biophysical characterization results, we describe how PTMs induce conformational changes in tau monomer and regulate tau aggregation. Compared to functional analysis of tau PTMs, biophysical characterization of tau PTMs is lagging. While it is challenging, characterizing the specific effects of PTMs on tau conformation and interaction is indispensable to unravel the tau PTM code.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Neurodegenerative disease; Post-translational modification; Protein aggregation; Tau protein; Tauopathies

Mesh:

Substances:

Year:  2022        PMID: 35325356     DOI: 10.1007/s12031-022-02002-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   2.866


  213 in total

Review 1.  Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.

Authors:  Hasan A M M Almansoub; Hui Tang; Ying Wu; Ding-Qi Wang; Yacoubou Abdoul Razak Mahaman; Na Wei; Yusra A M Almansob; Wei He; Dan Liu
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.

Authors:  Measho H Abreha; Eric B Dammer; Lingyan Ping; Tian Zhang; Duc M Duong; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2018-10       Impact factor: 3.984

3.  Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation.

Authors:  Elias Akoury; Marcus Pickhardt; Michal Gajda; Jacek Biernat; Eckhard Mandelkow; Markus Zweckstetter
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-11       Impact factor: 15.336

4.  Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments.

Authors:  A Alonso ; T Zaidi; M Novak; I Grundke-Iqbal; K Iqbal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

5.  Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration.

Authors:  Alejandra D Alonso; John Di Clerico; Bin Li; Christopher P Corbo; Maria E Alaniz; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

6.  A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.

Authors:  Deepa Ajit; Hanna Trzeciakiewicz; Jui-Heng Tseng; Connor M Wander; Youjun Chen; Aditi Ajit; Diamond P King; Todd J Cohen
Journal:  J Biol Chem       Date:  2019-09-22       Impact factor: 5.157

7.  TBK1 interacts with tau and enhances neurodegeneration in tauopathy.

Authors:  Measho H Abreha; Shamsideen Ojelade; Eric B Dammer; Zachary T McEachin; Duc M Duong; Marla Gearing; Gary J Bassell; James J Lah; Allan I Levey; Joshua M Shulman; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2021-05-07       Impact factor: 5.157

8.  Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau.

Authors:  Susmitha Ambadipudi; Jacek Biernat; Dietmar Riedel; Eckhard Mandelkow; Markus Zweckstetter
Journal:  Nat Commun       Date:  2017-08-17       Impact factor: 14.919

Review 9.  Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.

Authors:  Carolina Alquezar; Shruti Arya; Aimee W Kao
Journal:  Front Neurol       Date:  2021-01-07       Impact factor: 4.003

10.  Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins.

Authors:  Joanna Abi Habib; Etienne De Plaen; Vincent Stroobant; Dusan Zivkovic; Marie-Pierre Bousquet; Benoît Guillaume; Khadija Wahni; Joris Messens; Antonia Busse; Nathalie Vigneron; Benoit J Van den Eynde
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.